Cargando…
Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182158/ https://www.ncbi.nlm.nih.gov/pubmed/36928308 http://dx.doi.org/10.1007/s00277-023-05166-w |
| _version_ | 1785041730915008512 |
|---|---|
| author | Schalk, Enrico Jentsch-Ullrich, Kathleen |
| author_facet | Schalk, Enrico Jentsch-Ullrich, Kathleen |
| author_sort | Schalk, Enrico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10182158 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101821582023-05-14 Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma Schalk, Enrico Jentsch-Ullrich, Kathleen Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2023-03-16 2023 /pmc/articles/PMC10182158/ /pubmed/36928308 http://dx.doi.org/10.1007/s00277-023-05166-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Schalk, Enrico Jentsch-Ullrich, Kathleen Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma |
| title | Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma |
| title_full | Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma |
| title_fullStr | Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma |
| title_full_unstemmed | Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma |
| title_short | Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma |
| title_sort | evidence of bendamustine plus rituximab for old and frail patients with aggressive b-cell lymphoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182158/ https://www.ncbi.nlm.nih.gov/pubmed/36928308 http://dx.doi.org/10.1007/s00277-023-05166-w |
| work_keys_str_mv | AT schalkenrico evidenceofbendamustineplusrituximabforoldandfrailpatientswithaggressivebcelllymphoma AT jentschullrichkathleen evidenceofbendamustineplusrituximabforoldandfrailpatientswithaggressivebcelllymphoma |